$23.72
Currently 17 wall-street analysts regularly analyze the financials of Viking Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Viking Therapeutics, Inc. (VKTX) have a share price target of $95.44. This median of share price forecast represents a 302.38% upside from the latest price of $23.72 as on 24.04.25.
As per the chart shown above, analysts believe that the Viking Therapeutics, Inc. (VKTX) share price will touch around $95.44 in next 12-months.
Below is a chart showing the percentage difference between Viking Therapeutics, Inc.'s share price and its median forecast price. As on 24.04.25, the difference is -74.95%
Based on 17 analysts tracking and researching Viking Therapeutics, Inc. (VKTX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 7 | 8 | 8 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |